These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16971324)

  • 1. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N
    J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin a for aesthetic contouring of enlarged medial gastrocnemius muscle.
    Lee HJ; Lee DW; Park YH; Cha MK; Kim HS; Ha SJ
    Dermatol Surg; 2004 Jun; 30(6):867-71; discussion 871. PubMed ID: 15171764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
    Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT; Al-Qudah MA
    Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
    Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S; Ryan P; Sleeman D
    J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey-Hailey disease.
    Koeyers WJ; Van Der Geer S; Krekels G
    J Dermatolog Treat; 2008; 19(4):251-4. PubMed ID: 18629693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of botulinum toxin A on muscle histology during distraction osteogenesis.
    Olabisi R; Chamberlain CS; Petr S; Steiner S; Consigny D; Best TM; Vanderby R; Schultz E; Noonan KJ
    J Orthop Res; 2009 Mar; 27(3):310-7. PubMed ID: 18752291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A improves muscle spasms and rigidity in stiff-person syndrome.
    Liguori R; Cordivari C; Lugaresi E; Montagna P
    Mov Disord; 1997 Nov; 12(6):1060-3. PubMed ID: 9399238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of depression with botulinum toxin A: a case series.
    Finzi E; Wasserman E
    Dermatol Surg; 2006 May; 32(5):645-9; discussion 649-50. PubMed ID: 16706759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of phantom pain with botulinum-toxin A. A pilot study].
    Kern U; Martin C; Scheicher S; Müller H
    Schmerz; 2003 Apr; 17(2):117-24. PubMed ID: 12695892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M; Işeri PK
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for the treatment of congenital entropion.
    Christiansen G; Mohney BG; Baratz KH; Bradley EA
    Am J Ophthalmol; 2004 Jul; 138(1):153-5. PubMed ID: 15234303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.